Real-world prescription of anti-COVID-19 drugs in hospitalized patients with COVID-19 in Japan.
Haruka ShidaMaki KomamineKazuhiro KajiyamaTakashi WakiHotaka MaruyamaYoshiaki UyamaPublished in: PloS one (2024)
This study revealed the real-world situation of anti-COVID-19 drug prescriptions in hospitalized COVID-19 patients in Japan. A prescribed drug would depend on the latest scientific evidence, such as efficacy, safety, and approval status, at the time of prescription. Understanding the prescription of anti-COVID-19 drugs will be important for providing the most up-to-date treatments to patients and evaluating the benefit and/or risk of anti-COVID-19 drugs based on the utilization of an electronic medical record database.